Literature DB >> 30993589

Cancer Stem Cells: Acquisition, Characteristics, Therapeutic Implications, Targeting Strategies and Future Prospects.

Anoop K Yadav1, Neetin S Desai2.   

Abstract

Since last two decades, the major cancer research has focused on understanding the characteristic properties and mechanism of formation of Cancer stem cells (CSCs), due to their ability to initiate tumor growth, self-renewal property and multi-drug resistance. The discovery of the mechanism of acquisition of stem-like properties by carcinoma cells via epithelial-mesenchymal transition (EMT) has paved a way towards a deeper understanding of CSCs and presented a possible avenue for the development of therapeutic strategies. In spite of years of research, various challenges, such as identification of CSC subpopulation, lack of appropriate experimental models, targeting cancer cells and CSCs specifically without harming normal cells, are being faced while dealing with CSCs. Here, we discuss the biology and characteristics of CSCs, mode of acquisition of stemness (via EMT) and development of multi-drug resistance, the role of tumor niche, the process of dissemination and metastasis, therapeutic implications of CSCs and necessity of targeting them. We emphasise various strategies being developed to specifically target CSCs, including those targeting biomarkers, key pathways and microenvironment. Finally, we focus on the challenges that need to be subdued and propose the aspects that need to be addressed in future studies in order to broaden the understanding of CSCs and develop novel strategies to eradicate them in clinical applications. Graphical Abstract Cancer Stem Cells(CSCs) have gained much attention in the last few decades due to their ability to initiate tumor growth and, self-renewal property and multi-drug resistance. Here, we represent the CSC model of cancer, Characteristics of CSCs, acquisition of stemness and metastatic dissemination of cancer, Therapeutic implications of CSCs and Various strategies being employed to target and eradicate CSCs.

Entities:  

Keywords:  Epithelial-mesenchymal transition (EMT); Multi-drug resistance; Signaling pathways; angiogenesis; cancer recurrence; metastasis

Year:  2019        PMID: 30993589     DOI: 10.1007/s12015-019-09887-2

Source DB:  PubMed          Journal:  Stem Cell Rev Rep        ISSN: 2629-3277            Impact factor:   5.739


  235 in total

Review 1.  The hallmarks of cancer.

Authors:  D Hanahan; R A Weinberg
Journal:  Cell       Date:  2000-01-07       Impact factor: 41.582

Review 2.  Notch signaling: cell fate control and signal integration in development.

Authors:  S Artavanis-Tsakonas; M D Rand; R J Lake
Journal:  Science       Date:  1999-04-30       Impact factor: 47.728

Review 3.  Hedgehog signaling in animal development: paradigms and principles.

Authors:  P W Ingham; A P McMahon
Journal:  Genes Dev       Date:  2001-12-01       Impact factor: 11.361

4.  Hedgehog acts as a somatic stem cell factor in the Drosophila ovary.

Authors:  Y Zhang; D Kalderon
Journal:  Nature       Date:  2001-03-29       Impact factor: 49.962

5.  New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada.

Authors:  P Therasse; S G Arbuck; E A Eisenhauer; J Wanders; R S Kaplan; L Rubinstein; J Verweij; M Van Glabbeke; A T van Oosterom; M C Christian; S G Gwyther
Journal:  J Natl Cancer Inst       Date:  2000-02-02       Impact factor: 13.506

6.  Significance of multi-drug-resistant proteins in predicting chemotherapy response and prognosis in epithelial ovarian cancer.

Authors:  Y Yokoyama; S Sato; Y Fukushi; T Sakamoto; M Futagami; Y Saito
Journal:  J Obstet Gynaecol Res       Date:  1999-12       Impact factor: 1.730

Review 7.  Matrix metalloproteinases in tumour invasion and metastasis.

Authors:  S Curran; G I Murray
Journal:  J Pathol       Date:  1999-11       Impact factor: 7.996

8.  The ABCG2 transporter is an efficient Hoechst 33342 efflux pump and is preferentially expressed by immature human hematopoietic progenitors.

Authors:  Christian W Scharenberg; Michael A Harkey; Beverly Torok-Storb
Journal:  Blood       Date:  2002-01-15       Impact factor: 22.113

Review 9.  Mechanisms of cancer drug resistance.

Authors:  Michael M Gottesman
Journal:  Annu Rev Med       Date:  2002       Impact factor: 13.739

Review 10.  CD44 cell adhesion molecules.

Authors:  S Goodison; V Urquidi; D Tarin
Journal:  Mol Pathol       Date:  1999-08
View more
  34 in total

1.  Expression patterns and clinical significance of the potential cancer stem cell markers OCT4 and NANOG in colorectal cancer patients.

Authors:  Raheleh Roudi; Mahboubeh Barodabi; Zahra Madjd; Giandomenico Roviello; Silvia Paola Corona; Mahshid Panahei
Journal:  Mol Cell Oncol       Date:  2020-07-14

2.  TYMS-TM4SF4 axis promotes the progression of colorectal cancer by EMT and upregulating stem cell marker.

Authors:  Fen Zhang; Jiecheng Ye; Wenjing Guo; Fenfen Zhang; Liyuan Wang; Anjia Han
Journal:  Am J Cancer Res       Date:  2022-03-15       Impact factor: 6.166

3.  Rat Bone Marrow-Derived Mesenchymal Stem Cells Promote the Migration and Invasion of Colorectal Cancer Stem Cells.

Authors:  Weiyan Zou; Jie Zhao; Yi Li; Zishu Wang; Haiqin Yan; Yudong Liu; Meiqun Sun; Jialu Zhuang; Junbin Wang
Journal:  Onco Targets Ther       Date:  2020-07-07       Impact factor: 4.147

4.  The MyoD family inhibitor domain-containing protein enhances the chemoresistance of cancer stem cells in the epithelial state by increasing β-catenin activity.

Authors:  Chao-Ju Chen; Chih-Jen Yang; Sheau-Fang Yang; Ming-Shyang Huang; Yu-Peng Liu
Journal:  Oncogene       Date:  2020-01-07       Impact factor: 9.867

5.  PTTG1: a Unique Regulator of Stem/Cancer Stem Cells in the Ovary and Ovarian Cancer.

Authors:  Seema Parte; Irma Virant-Klun; Manish Patankar; Surinder K Batra; Alex Straughn; Sham S Kakar
Journal:  Stem Cell Rev Rep       Date:  2019-12       Impact factor: 6.692

6.  Enhanced Kat3A/Catenin transcription: a common mechanism of therapeutic resistance.

Authors:  Andrea Bild; Jia-Ling Teo; Michael Kahn
Journal:  Cancer Drug Resist       Date:  2019-09-19

7.  Inhibition of Migration, Invasion and Drug Resistance of Pancreatic Adenocarcinoma Cells - Role of Snail, Slug and Twist and Small Molecule Inhibitors.

Authors:  Ezgi Kaşıkcı; Esra Aydemir; Ömer Faruk Bayrak; Fikrettin Şahin
Journal:  Onco Targets Ther       Date:  2020-06-18       Impact factor: 4.147

Review 8.  Current understanding of epigenetics mechanism as a novel target in reducing cancer stem cells resistance.

Authors:  Saeedeh Keyvani-Ghamsari; Khatereh Khorsandi; Azhar Rasul; Muhammad Khatir Zaman
Journal:  Clin Epigenetics       Date:  2021-05-29       Impact factor: 6.551

Review 9.  Pluripotent Stem Cells: Cancer Study, Therapy, and Vaccination.

Authors:  Mojgan Barati; Maryam Akhondi; Narges Sabahi Mousavi; Newsha Haghparast; Asma Ghodsi; Hossein Baharvand; Marzieh Ebrahimi; Seyedeh-Nafiseh Hassani
Journal:  Stem Cell Rev Rep       Date:  2021-06-11       Impact factor: 5.739

Review 10.  Long non-coding RNAs towards precision medicine in gastric cancer: early diagnosis, treatment, and drug resistance.

Authors:  Li Yuan; Zhi-Yuan Xu; Shan-Ming Ruan; Shaowei Mo; Jiang-Jiang Qin; Xiang-Dong Cheng
Journal:  Mol Cancer       Date:  2020-05-27       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.